Glezer Stanislav 4
4 · Inogen Inc · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Inogen IncINGN
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2023-09-01$6.18/sh−394$2,435→ 7,591 total - Exercise/Conversion
Common Stock
2023-09-01+769→ 7,985 total - Exercise/Conversion
Restricted Stock Unit
2023-09-01−769→ 6,149 total→ Common Stock (769 underlying)
Footnotes (3)
- [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.